The INDDEP study: inpatient and day hospital treatment for depression – symptom course and predictors of change

BMC Psychiatry

Table 2 Instruments used the INDDEP study

Time point of measurement	Outcome/Variables	Patient	Research assistant
		(self-report)	(expert rating)
T0 (admission)	Depressive symptomatology:	QIDS-SR	QIDS-C, SKID-I
	Co-morbidity		SCID I + II
	Personality, interpersonal problems, mode of coping:	IIP-32, DEQ, DAS
	Overall disturbance and functioning:	SCL-90-R	SOFAS
	Social support:	F-SozU K-14
	Quality of Life:	SF-12
	Traumatisation:	CTQ
T1 (discharge)		QIDS-SR	QIDS-C
		SCL-90-R	SOFAS
		IIP-32
T2 (3-months Follow-up) and T3 (12-months Follow-up)		QIDS-SR	QIDS-C, LIFE-Interview
		SCL-90-R	SOFAS
		SF-12
		IIP-32

QIDS-SR = Quick Inventory of Depressive Symptoms, self-report form [23], QIDS-C = expert rating; SCID-I and SCID-II=Structured Clinical Interview for DSM IV axis I and II [24, 25]; SCL-90-R = Symptom-Check-List 90-R [26]; DAS = Dysfunctional Attitudes Scale [27, 28]; DEQ = Depressive Experiences Questionnaire [29, 30]; SOFAS = Social and Occupational Functioning Assessment Scale [31]; IIP-32 = Inventory of Interpersonal Problems, 32-item version [32, 33]; F-SozU K-14 = Fragebogen zur sozialen Unterstützung, 14-item version [34]; SF-12 = Fragebogen zum Gesundheitszustand (quality of life) [35]; CTQ = Childhood Trauma Questionnaire [36, 37]; LIFE-Interview = Longitudinal Interval Follow-up Evaluation [38].
Note: Additionally assessed at all time points of measurement: pharmacological treatment, somatic diagnoses; at T0: previous treatment for depression; at T1: documentation of treatment received (dose, components); T2 and T3: further outpatient treatment, days of sick leave, number of contacts to health care system.

ISSN: 1471-244X